Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: To establish the effectiveness and safety of Erbium:YAG (Er:YAG) laser treatment for the management of atrophic and urinary symptoms, due to the so-called Genitourinary Syndrome of Menopause (GSM) and stress incontinence.

Introduction: GSM represents a collection of symptoms and signs associated with aging and a decrease in estrogen and other sex steroids syndrome, including, but not limited to genital symptoms of dryness, burning and irritation; sexual symptoms of lack of lubrication, discomfort or pain, and impaired function; and, urinary symptoms of urgency, dysuria, incontinence and recurrent urinary tract infections.

Materials / method: Patients received three urethral and vaginal laser sessions of a 2940 nm Er:YAG laser in non-ablative mode, using a special vaginal robotic laser probe and a 4 mm intraurethral laser cannula, to promote an improvement in the tropism in both areas.

Results: All patients showed statistically-significant improvement over time during the 12 months following initial laser treatment. The overall improvement determined by VAS showed a great diminishment of the severity of the symptoms. Vaginal pH and MV showed the objective improvement of the vaginal symptoms in all patients. There were no serious adverse events during our study; however, some patients reported a mild discomfort during the laser procedure.

Conclusion: Through many years combined experience involving hundreds of patients, The application of vaginal and urethral non-ablative Er:YAG laser, using a special robotic laser probe and a 4 mm cannula, significantly improved the tropism of both vaginal mucosa and urethral mucosa, and its effects lasted up to 12 months. Randomized, controlled and prospective studies with larger number of patients and longer follow-up are needed to confirm our findings.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Teaching for ViVeve

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: educational grant